Hjem › Prostatakreft › Vermont
Kliniske studier for Prostatakreft i Vermont
5 studier for Prostatakreft søker deltakere på steder i Vermont.
Byer i Vermont
Offisiell studietekst (engelsk)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT06931340Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
- University of Vermont and State Agricultural College, Burlington
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 10. sep. 2026 · NCT05946213Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- Dartmouth Cancer Center - North, Saint Johnsbury
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 14. jul. 2026 · NCT06592924Fezolinetant for Treating Hot Flashes in Men With Prostate Cancer
- University of Vermont Medical Center, Burlington
RekruttererFase 2
Alder 18 og eldre · Menn · Oppdatert 5. feb. 2026 · NCT06972875Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- Central Vermont Medical Center/National Life Cancer Treatment, Berlin Corners
- University of Vermont Medical Center, Burlington
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 11. sep. 2025 · NCT03678025Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.